Objective: The aim of this study was to critically analyze the safety of the revised guidelines,
with focus on cyst size and worrisome features in the management of BD-IPMN …

Background A consensus conference has recommended close observation of branch duct
intraductal papillary mucinous neoplasms (BD-IPMNs) smaller than 30 mm, without …

Background The international consensus guidelines (the guidelines) for management of
intraductal papillary mucinous neoplasms (IPMNs) of the pancreas recommend surgical …

Background & Aims: The 2006 Sendai Consensus Guidelines recommend surgical
resection for all suspected branch-duct intraductal papillary mucinous neoplasm (BD-IPMN) …

Abstract Background The 2012 Sendai Criteria recommend that patients with 3 cm or larger
branch duct intraductal papillary mucinous neoplasms (BD-IPMN) without any additional …

Background & Aims Little is known about the development of branch duct intraductal
papillary mucinous neoplasms (BD-IPMNs). We evaluated long-term outcomes of a large …

METHODS We identified 147 patients with IPMN-Br of whom 66 underwent surgical
resection at diagnosis and 81 were followed conservatively, of whom 11 were resected …

Background Classifications of intraductal papillary mucinous neoplasm (IPMN) remain
ambiguous, especially for the mixed type. Factors predicting malignancy remain unclear …

Background and Aims Management of branch-duct intraductal papillary mucinous
neoplasms (BD-IPMNs) remains challenging. We determined factors associated with …

Background & Aims: Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas
arising in branch ducts are thought to be less aggressive than their main-duct counterparts …